HOME >> BIOLOGY >> NEWS
Four IU professors are 2004 Guggenheim Fellows

BLOOMINGTON, Ind. -- Four Indiana University Bloomington professors have been awarded Guggenheim fellowships, the Guggenheim Foundation announced today (April 8).

Professor of Central Eurasian Studies Christopher Beckwith, Professor Emeritus of Folklore and Ethnomusicology Mary Ellen Brown, Professor of Biology Ellen Ketterson and Distinguished Professor of Biology Loren Rieseberg are among the 2004 fellowship winners.

The 80-year-old Guggenheim fellowships are given "on the basis of distinguished achievement in the past and exceptional promise for future accomplishment," to "men and women devoted to science and liberal studies, great teachers, creators of beauty, and generally to those devoted to pursuits that dignify, ennoble and delight mankind," according to the foundation.

An expert on birds' sexual behavior, Ketterson will use her Guggenheim grant to do something unusual -- bringing contemporary studies of human sexual behavior to bear on similar studies in other animals. Usually, scientists extrapolate in the other direction. Ketterson will examine whether human sex and gender concepts apply in songbirds. Studies she will begin later this year in South Dakota, Nevada, Costa Rica and Mexico will examine how geographic differences in songbird behavior and physiology relate to sex and, possibly, gender. Ketterson is a member of IU's Center for the Integrative Study of Animal Behavior. She is also president of the Kinsey Institute's Board of Governors and has a part-time appointment in IUB's Gender Studies Program.

Rieseberg plans to use his Guggenheim grant to write The Origin and Evolution of Plant Species, a comprehensive, 11-chapter monograph that Rieseberg says will provide a much-needed update to plant biology texts currently available to botanical students and researchers. A leader in plant population genetics and evolution, Rieseberg plans to integrate much of his own scholarly work into the monograph. He also
'"/>

Contact: David Bricker
brickerd@indiana.edu
812-856-9035
Indiana University
8-Apr-2004


Page: 1 2

Related biology news :

1. University of Minnesota professors to speak at symposium on international trade
2. UT Southwestern scientist awarded prestigious American Cancer Society research professorship
3. Nominations sought for professorship by the American Association for Cancer Research
4. Howard Hughes Medical Institutes million dollar professors
5. Washington Universitys Sarah C. R. Elgin is one of 20 million dollar professors
6. K-State professors make discovery in pesticide-resistant bugs
7. Five Rutgers professors named fellows of national science association
8. 20 scientists selected as Aldo Leopold Leadership Fellows
9. UC San Diego places in top tier of institutions awarded 2004 Sloan Research Fellowships
10. Ten Chinese reporters receive AAAS Fellowships
11. Crops society announces Pioneer Fellowship in Plant Sciences

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Four professors are Guggenheim Fellows

(Date:10/22/2014)... Medicine® scientists helps explain how bipolar disorder affects the ... therapies to treat the mental illness. , Scientists ... method recognized with the 2014 Nobel Prize in ... from mice with bipolar-like behaviors. In the synapses (where ... structures with concentrated levels of ANK3 -- the gene ...
(Date:10/22/2014)... , Oct. 20, 2014  Leading identity analyst firm ... half of the world,s population will have a chip-based ... Europe . Asia , ... market accounting for more than 60% of all National ... Acuity,s report  -- "The Global National eID ...
(Date:10/19/2014)... in India over the last 30 years contributed ... growth during that time, according to a new ... Change ., "Energy access is fundamental to development: ... including education, communication, and health," says IIASA researcher ... increased energy access is widely agreed to be ...
Breaking Biology News(10 mins):Bipolar disorder discovery at the nano level 2Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Improved electricity access has little impact on climate change 2
(Date:10/25/2014)... , October 24, 2014 ... Corporation (NASDAQ: CYTR ), Vertex Pharmaceuticals Inc. ... ALXN ), Peregrine Pharmaceuticals Inc. (NASDAQ: ... research on these five companies can be accessed at: ... Thursday, October 23, 2014, ended on a positive note ...
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis ... specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today ... to acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., ... for the treatment of diabetic gastroparesis and other GI ... successful Phase 2 trial of relamorelin for the treatment ...
(Date:10/22/2014)... WriteResult, LLC – a premier provider of ... a team of researchers from Yale University’s School of ... to provide electronic questionnaire data collection through use of ... in May, aims to evaluate the impact of a ... and participation in urban agriculture to impact their consumption ...
(Date:10/22/2014)... ROCKVILLE, Md. , Oct. 22, 2014   ... company developing novel pathogen-specific therapies for serious infections and ... Office has issued a Notice of Allowance for a ... product in its C. difficile program, SYN-004. This ... to SYN-004 in the U.S. and adds to the ...
Breaking Biology Technology:Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4
Cached News: